Home
>
National Drug Code (NDC)
>
TEMODAR
TEMODAR - 0085-1417-01 - (Temozolomide)
Drug Information of TEMODAR
| Product NDC: | 0085-1417 |
| Proprietary Name: | TEMODAR |
| Non Proprietary Name: | Temozolomide |
| Active Ingredient(s): | 250 mg/1 & nbsp; Temozolomide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of TEMODAR
| Product NDC: | 0085-1417 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021029 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19990811 |
Package Information of TEMODAR
| Package NDC: | 0085-1417-01 |
| Package Description: | 1 BOTTLE, GLASS in 1 CARTON (0085-1417-01) > 5 CAPSULE in 1 BOTTLE, GLASS |
NDC Information of TEMODAR
| NDC Code | 0085-1417-01 |
| Proprietary Name | TEMODAR |
| Package Description | 1 BOTTLE, GLASS in 1 CARTON (0085-1417-01) > 5 CAPSULE in 1 BOTTLE, GLASS |
| Product NDC | 0085-1417 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Temozolomide |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 19990811 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | TEMOZOLOMIDE |
| Strength Number | 250 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Alkylating Activity [MoA],Alkylating Drug [EPC] |
